Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Vertex Pharmaceutic (VRTX)
Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 91,206,912
  • Shares Outstanding, K 257,683
  • Annual Sales, $ 8,931 M
  • Annual Income, $ 3,322 M
  • 60-Month Beta 0.42
  • Price/Sales 10.20
  • Price/Cash Flow 25.32
  • Price/Book 5.54
Trade VRTX with:

Options Overview Details

View History
  • Implied Volatility 28.92% ( -5.03%)
  • Historical Volatility 27.23%
  • IV Percentile 84%
  • IV Rank 64.31%
  • IV High 34.84% on 02/02/23
  • IV Low 18.25% on 08/07/23
  • Put/Call Vol Ratio 0.72
  • Today's Volume 383
  • Volume Avg (30-Day) 2,995
  • Put/Call OI Ratio 1.11
  • Today's Open Interest 62,939
  • Open Int (30-Day) 55,532

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate 3.84
  • Number of Estimates 12
  • High Estimate 4.23
  • Low Estimate 3.43
  • Prior Year 3.33
  • Growth Rate Est. (year over year) +15.32%

Price Performance

See More
Period Period Low Period High Performance
1-Month
341.90 +2.85%
on 11/16/23
381.59 -7.85%
on 11/14/23
-25.32 (-6.72%)
since 11/08/23
3-Month
341.85 +2.87%
on 10/03/23
387.42 -9.23%
on 11/06/23
+8.60 (+2.51%)
since 09/08/23
52-Week
282.21 +24.60%
on 01/09/23
387.42 -9.23%
on 11/06/23
+30.32 (+9.44%)
since 12/08/22

Most Recent Stories

More News
CRISPR Therapeutics Just Slashed Its Staff by 10%. Should Shareholders Be Worried?

The timing of the cuts is setting off alarm bells, but the situation is under control.

VRTX : 351.24 (-0.77%)
CRSP : 74.40 (+5.97%)
This Newly Discovered Risk Could Be a Big Headache for Vertex Pharmaceuticals and CRISPR Therapeutics

Shareholders will do well to prepare themselves for how regulators might react.

VRTX : 351.24 (-0.77%)
CRSP : 74.40 (+5.97%)
5 Unstoppable Trends to Invest $1,000 in for 2024

These next-big-thing trends represent some of the most exciting moneymaking opportunities for investors next year.

CRWD : 241.39 (+0.51%)
OKTA : 73.40 (+1.94%)
VRTX : 351.24 (-0.77%)
CRSP : 74.40 (+5.97%)
PYPL : 59.42 (+1.61%)
AMT : 208.34 (-1.13%)
WDC : 47.69 (+0.80%)
AMZN : 146.92 (+0.03%)
GOOGL : 135.98 (-0.69%)
GOOG : 137.66 (-0.57%)
LOVE : 24.90 (+0.08%)
Better Growth Stock: CRISPR Therapeutics vs. Invitae

One of these stocks may be riskier than the other...

AAPL : 194.70 (+0.22%)
AMZN : 146.92 (+0.03%)
VRTX : 351.24 (-0.77%)
CRSP : 74.40 (+5.97%)
NVTA : 0.5686 (-0.92%)
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.

The gene-editing revolution is unfolding at a record pace. Still, risks abound, and picking individual stocks may not be the wisest approach.

CRSP : 74.40 (+5.97%)
BEAM : 27.76 (-3.44%)
CRBU : 6.10 (+2.52%)
EDIT : 10.99 (+0.83%)
NTLA : 30.24 (+1.54%)
PRME : 8.45 (-1.29%)
VERV : 13.17 (+2.01%)
LLY : 592.04 (+0.64%)
REGN : 841.88 (-0.86%)
VRTX : 351.24 (-0.77%)
ARKG : 29.03 (+1.11%)
HOOD : 11.62 (+1.22%)
A Bull Market Is Coming. Here Are 3 Stocks You'll Absolutely Want to Own.

These stocks are already big winners in 2023 and should keep their momentum going in a new bull market.

MSFT : 372.25 (+0.35%)
AMZN : 146.92 (+0.03%)
VRTX : 351.24 (-0.77%)
Where Will Vertex Pharmaceuticals Be in 10 Years?

Vertex shares have soared 400% over the past decade.

CRSP : 74.40 (+5.97%)
MRNA : 81.12 (+1.46%)
VRTX : 351.24 (-0.77%)
3 No-Brainer Growth Stocks to Buy in December

No analysis paralysis is required with these great stocks.

NKE : 115.69 (+0.77%)
LLY : 592.04 (+0.64%)
NVO : 96.91 (+0.10%)
VRTX : 351.24 (-0.77%)
Got $5,000? These Are 2 of the Best Growth Stocks to Buy Right Now

The one thing these two stocks have in common is tremendous growth prospects.

AAPL : 194.70 (+0.22%)
EBAY : 41.61 (+0.31%)
CRSP : 74.40 (+5.97%)
PYPL : 59.42 (+1.61%)
VRTX : 351.24 (-0.77%)
5 Top Stocks to Buy Before 2024

These stocks have room to run -- next year and over the long term.

CRSP : 74.40 (+5.97%)
LLY : 592.04 (+0.64%)
VRTX : 351.24 (-0.77%)
ISRG : 311.86 (+0.10%)
PFE : 28.79 (+0.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which...

See More

Key Turning Points

3rd Resistance Point 362.24
2nd Resistance Point 358.71
1st Resistance Point 356.33
Last Price 350.66
1st Support Level 350.43
2nd Support Level 346.90
3rd Support Level 344.52

See More

52-Week High 387.42
Last Price 350.66
Fibonacci 61.8% 347.23
Fibonacci 50% 334.82
Fibonacci 38.2% 322.40
52-Week Low 282.21

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar